Spdr Sp Biotech Etf Performance

XBI Etf  USD 120.94  1.07  0.88%   
The entity has a beta of 1.06, which indicates a somewhat significant risk relative to the market. SPDR SP returns are very sensitive to returns on the market. As the market goes up or down, SPDR SP is expected to follow.

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in SPDR SP Biotech are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Despite fairly abnormal fundamental drivers, SPDR SP demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
1
Analyst Says Hes Buying This Biotech ETF, Predicts Multi-Year Breakout
10/21/2025
2
Nvwm LLC Raises Position in SPDR SP Biotech ETF XBI
11/07/2025
3
SPDR SP Biotech ETF Reaches New 52-Week High Heres What Happened
11/11/2025
4
SPDR SP Biotech ETF XBI Shares Purchased by Prospera Financial Services Inc
11/14/2025
5
Biotech ETF Hits New 52-Week High
11/17/2025
6
SPDR SP Biotech ETF Target of Unusually High Options Trading
11/18/2025
7
Is State Street SPDR SP Biotech ETF a Strong ETF Right Now
11/19/2025
8
Apple, Taiwan Semiconductor Manufacturing And More On CNBCs Final Trades
11/25/2025
9
Steward Partners Investment Advisory LLC Has 1.10 Million Stock Holdings in SPDR SP Biotech ETF XBI
12/02/2025
10
SPDR SP Biotech ETF XBI Position Reduced by Jump Financial LLC
12/08/2025

SPDR SP Relative Risk vs. Return Landscape

If you would invest  9,665  in SPDR SP Biotech on September 18, 2025 and sell it today you would earn a total of  2,429  from holding SPDR SP Biotech or generate 25.13% return on investment over 90 days. SPDR SP Biotech is generating 0.3604% of daily returns assuming volatility of 1.387% on return distribution over 90 days investment horizon. In other words, 12% of etfs are less volatile than SPDR, and above 93% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon SPDR SP is expected to generate 1.96 times more return on investment than the market. However, the company is 1.96 times more volatile than its market benchmark. It trades about 0.26 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.1 per unit of risk.

SPDR SP Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for SPDR SP's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as SPDR SP Biotech, and traders can use it to determine the average amount a SPDR SP's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.2598

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsXBI
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns
Based on monthly moving average SPDR SP is performing at about 20% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SPDR SP by adding it to a well-diversified portfolio.

SPDR SP Fundamentals Growth

SPDR Etf prices reflect investors' perceptions of the future prospects and financial health of SPDR SP, and SPDR SP fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on SPDR Etf performance.

About SPDR SP Performance

By evaluating SPDR SP's fundamental ratios, stakeholders can gain valuable insights into SPDR SP's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if SPDR SP has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if SPDR SP has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
In seeking to track the performance of the SP Biotechnology Select Industry Index , the fund employs a sampling strategy. SP Biotech is traded on NYSEARCA Exchange in the United States.
Latest headline from news.google.com: VYMI Over IDV Forget The Higher Yield, Its All About Quality And Growth - Seeking Alpha
The fund generated five year return of -3.0%
SPDR SP Biotech keeps 99.97% of its net assets in stocks
When determining whether SPDR SP Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of SPDR SP's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Spdr Sp Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Spdr Sp Biotech Etf:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in SPDR SP Biotech. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
The market value of SPDR SP Biotech is measured differently than its book value, which is the value of SPDR that is recorded on the company's balance sheet. Investors also form their own opinion of SPDR SP's value that differs from its market value or its book value, called intrinsic value, which is SPDR SP's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SPDR SP's market value can be influenced by many factors that don't directly affect SPDR SP's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SPDR SP's value and its price as these two are different measures arrived at by different means. Investors typically determine if SPDR SP is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SPDR SP's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.